RSS Feeds
Helicobacter pylori and Idiopathic Thrombocytopenic Purpura
- Francesco Franceschi, MD;
- Nicholas Christodoulides, PhD;
- Michael H. Kroll, MD; and
- Robert M. Genta, MD
- From Catholic University of Rome, 00168 Rome, Italy; and Baylor College of Medicine and Veterans Affairs Medical Center, Houston, TX 77030.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Background: Idiopathic thrombocytopenic purpura (ITP) is a hematologic disorder characterized by sensitization of platelets by autoantibodies leading to platelet destruction (1-4). Although its cause remains unclear, ITP is associated with several diseases, including infections (5-8).
Helicobacter pylori, a gram-negative bacterium, is a frequent cause of upper gastrointestinal tract infection (9). Of interest, the presence of …
